GSK plc.
Company Snapshot
Company Overview
GSK plc., a science-led global healthcare company, was established in 1715. In 2000, Glaxo Wellcome and SmithKline Beecham merged to create GlaxoSmithKline PLC, which offers a wide range of product portfolios. It provides major pharmaceutical products and comprises medication in the therapeutic areas of antibacterial, antivirals, cardiovascular, central nervous system, dermatology, HIV, immuno-inflammation, metabolic, oncology, respiratory, and urogenital.
It operates its business through its three segments: specialty medicine, vaccines, and general medicine. The pharmaceutical division covers a range of acute and chronic diseases. The consumer healthcare division is further segmented into wellness, oral health, nutrition, and skin health. The company's consumer healthcare business is focused on pain relief, respiratory, oral health, skin health, and nutrition/gastrointestinal health.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
GSK plc. In News
Company's Business Segments
- Speciality Medicines : HIV, Oncology, Immuno-inflammation, respiratory and other
- Vaccines : Meningitis, Influenza, Shingles, Established Vaccines
- General Medicines : Respiratory, Other General Medicines
Applications/End User Industries
- Healthcare Providers
- Hospitals
- Pharmacies
- Wholesalers
- Governments
- Research Institutions
- Pharmaceutical Companies